Helen Philippou

4.9k total citations
75 papers, 3.8k citations indexed

About

Helen Philippou is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Helen Philippou has authored 75 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 42 papers in Pulmonary and Respiratory Medicine and 19 papers in Genetics. Recurrent topics in Helen Philippou's work include Blood properties and coagulation (39 papers), Blood Coagulation and Thrombosis Mechanisms (28 papers) and Platelet Disorders and Treatments (21 papers). Helen Philippou is often cited by papers focused on Blood properties and coagulation (39 papers), Blood Coagulation and Thrombosis Mechanisms (28 papers) and Platelet Disorders and Treatments (21 papers). Helen Philippou collaborates with scholars based in United Kingdom, United States and Netherlands. Helen Philippou's co-authors include David A. Lane, Robert A.S. Ariëns, Peter J. Grant, Beverley J. Hunt, James A. Huntington, Sajila Sheikh, M Boisclair, Nicola J. Mutch, M. P. Esnouf and Gordon Lowe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Helen Philippou

72 papers receiving 3.7k citations

Peers

Helen Philippou
Nicola J. Mutch United Kingdom
Victor Gurewich United States
Laurent O. Mosnier United States
Rodger L. Bick United States
Henry M. Rinder United States
F Bachmann Switzerland
Daniel D. Myers United States
Nicola J. Mutch United Kingdom
Helen Philippou
Citations per year, relative to Helen Philippou Helen Philippou (= 1×) peers Nicola J. Mutch

Countries citing papers authored by Helen Philippou

Since Specialization
Citations

This map shows the geographic impact of Helen Philippou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Philippou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Philippou more than expected).

Fields of papers citing papers by Helen Philippou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Philippou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Philippou. The network helps show where Helen Philippou may publish in the future.

Co-authorship network of co-authors of Helen Philippou

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Philippou. A scholar is included among the top collaborators of Helen Philippou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Philippou. Helen Philippou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kearney, Katherine J., Henri M.H. Spronk, Jonas Emsley, Nigel S. Key, & Helen Philippou. (2023). Plasma Kallikrein as a Forgotten Clotting Factor. Seminars in Thrombosis and Hemostasis. 50(7). 953–961. 9 indexed citations
3.
Pezeshkpoor, Behnaz, Johannes Dodt, Amit Sharma, et al.. (2023). Heterozygosity in factor XIII genes and the manifestation of mild inherited factor XIII deficiency. Journal of Thrombosis and Haemostasis. 22(2). 379–393. 3 indexed citations
4.
Hethershaw, Emma, Majid Ali, Richard Foster, et al.. (2023). Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems. Journal of Thrombosis and Haemostasis. 21(4). 814–827. 3 indexed citations
5.
Foster, Holly, Clare Wilson, Julia S. Gauer, et al.. (2022). A Comparative Assessment Study of Known Small-molecule GPVI Modulators. ACS Medicinal Chemistry Letters. 13(2). 171–181. 6 indexed citations
6.
Wilson, Clare, et al.. (2022). Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation. Research and Practice in Thrombosis and Haemostasis. 6(4). e12715–e12715. 5 indexed citations
7.
McPherson, Helen R., Cédric Duval, Stephen R. Baker, et al.. (2021). Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability, and resistance to fibrinolysis. eLife. 10. 21 indexed citations
8.
Duval, Cédric, Majid Ali, Nadira Yuldasheva, et al.. (2021). Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi. Proceedings of the National Academy of Sciences. 118(27). 20 indexed citations
9.
Kearney, Katherine J., Clare Wilson, Majid Ali, et al.. (2021). Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI. Proceedings of the National Academy of Sciences. 118(3). 46 indexed citations
10.
Gauer, Julia S., Nicoletta Riva, Helen Philippou, et al.. (2020). Effect of anticoagulants on fibrin clot structure: A comparison between vitamin K antagonists and factor Xa inhibitors. Research and Practice in Thrombosis and Haemostasis. 4(8). 1269–1281. 24 indexed citations
11.
Khan, Ahsan Ali, et al.. (2020). Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant. Thrombosis Research. 197. 69–76. 1 indexed citations
12.
Singh, Sneha, Johannes Dodt, Peter Volkers, et al.. (2019). Structure functional insights into calcium binding during the activation of coagulation factor XIII A. Scientific Reports. 9(1). 11324–11324. 69 indexed citations
13.
Anokhin, Boris A., William L. Dean, Kerrie A. Smith, et al.. (2019). Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A. FEBS Journal. 287(3). 452–464. 15 indexed citations
14.
Macrae, Fraser L., Cédric Duval, Praveen Papareddy, et al.. (2018). A fibrin biofilm covers blood clots and protects from microbial invasion. Journal of Clinical Investigation. 128(8). 3356–3368. 95 indexed citations
15.
Hethershaw, Emma, Penelope J. Adamson, Kerrie A. Smith, et al.. (2018). The role of β‐barrels 1 and 2 in the enzymatic activity of factor XIII A‐subunit. Journal of Thrombosis and Haemostasis. 16(7). 1391–1401. 7 indexed citations
16.
Gupta, Sneha, Arijit Biswas, Mohammad Suhail Akhter, et al.. (2016). Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective. Scientific Reports. 6(1). 30105–30105. 31 indexed citations
17.
Cate‐Hoek, Arina J. ten, Jeffrey I. Weitz, David Gailani, et al.. (2015). Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS). Thrombosis Research. 136. S13–S18. 2 indexed citations
18.
Duval, Cédric, et al.. (2014). Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function. Thrombosis and Haemostasis. 112(5). 842–850. 65 indexed citations
19.
Duval, Cédric, Helen Philippou, Sherina L. Murden, et al.. (2013). Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis. Thrombosis and Haemostasis. 110(12). 1135–1144. 9 indexed citations
20.
Lowe, Gordon, Ann Rumley, Mark Woodward, et al.. (1997). EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE. British Journal of Haematology. 97(4). 775–784. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026